Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Study of the Safety, Tolerability, Food Effect and Pharmacokinetics of DA414 Granules After Single and Multiple Administration in Healthy Subjects

NCT06525168 is registered in ClinicalTrials.gov with Chendu DIAO Nine Hong Pharmaceutical Factory as lead sponsor.

NCT NCT06525168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06525168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Study of the Safety, Tolerability, Food Effect and Pharmacokinetics of DA414 Granules After Single and Multiple Administration in Healthy Subjects
Lead sponsor
Chendu DIAO Nine Hong Pharmaceutical Factory
Phase
Phase 1
Overall status
Recruiting
Start date
February 6, 2024
Completion date
September 30, 2026
Enrollment
82 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke